Biotage AB Acquires MIP Technologies AB, Developer of Molecularly Imprinted Polymer Technology

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Biotage AB (STO:BIOTA) a global leader in tools and technology for medicinal and analytical chemistry, and the owners of MIP Technologies AB today announced that the parties have signed a definitive agreement under which Biotage will acquire all outstanding shares in MIP Technologies, a privately held leading developer of molecularly imprinted polymers (MIPs) and other novel polymers.

Back to news